Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells

P. Kharaziha, P. Rodriguez, Q. Li, H. Rundqvist, A. C. Björklund, M. Augsten, A. Ullén, L. Egevad, P. Wiklund, S. Nilsson, G. Kroemer, D. Grander, T. Panaretakis

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Targeting of distinct signaling cascades and cancer-associated fibroblasts define the efficacy of Sorafenib against prostate cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences